These results indicated that the anti‐HBx antibody may have chemopreventive applications and could control the migration and invasion of HBx‐expressing HCC cells through the activated B56γ‐mediated dephosphorylation of p‐AKTThr308/Ser473. The gene discussed is PPP2R5C; the disease is hepatocellular carcinoma.